Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
Q3 2023 vs. Q2 2023
How the institutions holding Aclarion, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 13 | 9 | −4 |
| Shares | 615.7K | 538.4K | −77.3K (−12.6%) |
| Value | $423.6K | $175.9K | −$247.7K (−58.5%) |
New holders (2)
Institutions that held Aclarion, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 31,316 | $10.6K | 0.00% |
| UBS Group AG | 134 | $44 | 0.00% |
Sold out (6)
Institutions that held Aclarion, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| HRT Financial LP | 50,081 | $34.0K |
| Jane Street Group, LLC | 37,517 | $25.9K |
| Virtu Financial LLC | 35,143 | $24.0K |
| Commonwealth Equity Services, LLC | 20,430 | $14.0K |
| Two Sigma Securities, LLC | 14,122 | $9.74K |
| V Wealth Advisors LLC | 10,000 | $6.90K |